Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Influenza

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 516 articles:
HTML format
Text format



Single Articles


    July 2019
  1. GOCKO X, Poulteau S, Beyens MN, Bertholon P, et al
    Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30916.
    PubMed     Text format     Abstract available


  2. SHELDENKAR A, Lim F, Yung CF, Lwin MO, et al
    Acceptance and uptake of influenza vaccines in Asia: A systematic review.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30889.
    PubMed     Text format     Abstract available


  3. KINGSTAD-BAKKE BA, Chandrasekar SS, Phanse Y, Ross KA, et al
    Effective mosaic-based nanovaccines against avian influenza in poultry.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30854.
    PubMed     Text format     Abstract available


  4. BRESEE JS, Lafond KE, McCarron M, Azziz-Baumgartner E, et al
    The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Vaccine. 2019 Jul 6. pii: S0264-410X(19)30811.
    PubMed     Text format     Abstract available


  5. MOSER MJ, Hatta Y, Gabaglia C, Sanchez A, et al
    Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30805.
    PubMed     Text format     Abstract available


  6. PARKER L, Ritter L, Wu W, Maeso R, et al
    Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A/H1N1pdm09 viruses in the 2013-2014 and 2015-2016 seasons.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30777.
    PubMed     Text format     Abstract available


  7. BRIGGS L, Fronek P, Quinn V, Wilde T, et al
    Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia.
    Vaccine. 2019 Jul 2. pii: S0264-410X(19)30856.
    PubMed     Text format     Abstract available


  8. DURALLIU A, Matejtschuk P, Dubey S, Koroma H, et al
    The influence of the closure format on the storage stability and moisture content of freeze-dried influenza antigen.
    Vaccine. 2019 Jul 2. pii: S0264-410X(19)30847.
    PubMed     Text format     Abstract available


    June 2019
  9. CORONEL J, Behrendt I, Burgin T, Anderlei T, et al
    Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30764.
    PubMed     Text format     Abstract available


  10. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30843.
    PubMed     Text format     Abstract available


  11. HAUSER MI, Muscatello DJ, Soh ACY, Dwyer DE, et al
    An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30801.
    PubMed     Text format     Abstract available


  12. DE OLIVEIRA BERNARDO C, Gonzalez-Chica DA, Chilver M, Stocks N, et al
    Influenza immunisation coverage from 2015 to 2017: A national study of adult patients from Australian general practice.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30819.
    PubMed     Text format     Abstract available


  13. SINGH G, Zholobko O, Pillatzki A, Webb B, et al
    An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.
    Vaccine. 2019 Jun 21. pii: S0264-410X(19)30792.
    PubMed     Text format     Abstract available


  14. KWONG JC, Buchan SA, Chung H, Campitelli MA, et al
    Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Vaccine. 2019 Jun 17. pii: S0264-410X(19)30772.
    PubMed     Text format     Abstract available


  15. MURTI M, Otterstatter M, Orth A, Balshaw R, et al
    Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.
    Vaccine. 2019 Jun 13. pii: S0264-410X(19)30775.
    PubMed     Text format     Abstract available


  16. DEMARCUS L, Shoubaki L, Federinko S
    Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30763.
    PubMed     Text format     Abstract available


  17. NORDIN JD, Vazquez-Benitez G, Olsen A, Kuckler LC, et al
    Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.
    Vaccine. 2019 Jun 10. pii: S0264-410X(19)30718.
    PubMed     Text format     Abstract available


  18. SHINJOH M, Sugaya N, Furuichi M, Araki E, et al
    Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30747.
    PubMed     Text format     Abstract available


  19. LIAO Q, Lam WWT, Wong CKH, Lam C, et al
    The relative effects of determinants on Chinese adults' decision for influenza vaccination choice: What is the effect of priming?
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30709.
    PubMed     Text format     Abstract available


  20. BORG K, Sutton K, Beasley M, Tull F, et al
    Reply to letter to the editor in response to the article "Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial".
    Vaccine. 2019;37:3382.
    PubMed     Text format    


    May 2019
  21. NG Y, Nandar K, Chua LAV, Mak TM, et al
    Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30388.
    PubMed     Text format     Abstract available


  22. KEITEL WA, Voronca DC, Atmar RL, Paust S, et al
    Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30554.
    PubMed     Text format     Abstract available


  23. YAKUBOGULLARI N, Genc R, Coven F, Nalbantsoy A, et al
    Development of adjuvant nanocarrier systems for seasonal influenza A (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS).
    Vaccine. 2019 May 30. pii: S0264-410X(19)30662.
    PubMed     Text format     Abstract available


  24. NICOLODI C, Groiss F, Kiselev O, Wolschek M, et al
    Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30627.
    PubMed     Text format     Abstract available


  25. BA-NGUZ A, Shah A, Bresee JS, Lafond KE, et al
    Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
    Vaccine. 2019 May 23. pii: S0264-410X(19)30670.
    PubMed     Text format     Abstract available


  26. LAESTADIUS A, Ingelman-Sundberg HM, Myrberg IH, Verme A, et al
    Altered proportions of circulating CXCR5+ helper T cells do not dampen influenza vaccine responses in children with rheumatic disease.
    Vaccine. 2019 May 21. pii: S0264-410X(19)30661.
    PubMed     Text format     Abstract available


  27. PEREZ-VILAR S, Wernecke M, Arya D, Lo AC, et al
    Surveillance for Guillain-Barre syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30665.
    PubMed     Text format     Abstract available


  28. KOUL PA, Bali NK, Koul HP
    Influenza vaccination for Hajj for the next decade: A case for quadrivalent SH vaccine.
    Vaccine. 2019 May 16. pii: S0264-410X(19)30602.
    PubMed     Text format    


  29. MANNING J, Dunne EM, Wang N, Pedersen JS, et al
    Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30324.
    PubMed     Text format     Abstract available


  30. KO EJ, Lee Y, Lee YT, Jung YJ, et al
    Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.
    Vaccine. 2019 May 14. pii: S0264-410X(19)30632.
    PubMed     Text format     Abstract available


  31. FELDMAN RA, Fuhr R, Smolenov I, Mick Ribeiro A, et al
    mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
    Vaccine. 2019 May 9. pii: S0264-410X(19)30562.
    PubMed     Text format     Abstract available


  32. AWAD S, Abdo N, Yusef D, Jawarneh A, et al
    Knowledge, attitudes and practices related to influenza illness and vaccination in children: Role of awareness campaigns in changing parents' attitudes toward influenza vaccination in Jordan.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30571.
    PubMed     Text format     Abstract available


  33. BONOMO ME, Kim RY, Deem MW
    Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season.
    Vaccine. 2019 May 3. pii: S0264-410X(19)30417.
    PubMed     Text format     Abstract available


    April 2019
  34. DOYON-PLOURDE P, Fakih I, Tadount F, Fortin E, et al
    Impact of influenza vaccination on healthcare utilization - A systematic review.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30525.
    PubMed     Text format     Abstract available


  35. BISSINGER T, Fritsch J, Mihut A, Wu Y, et al
    Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30528.
    PubMed     Text format     Abstract available


  36. COHET C, van der Most R, Bauchau V, Bekkat-Berkani R, et al
    Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
    Vaccine. 2019 Apr 25. pii: S0264-410X(19)30522.
    PubMed     Text format     Abstract available


  37. XEUATVONGSA A, Mott JA, Khanthamaly V, Patthammavong C, et al
    Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.
    Vaccine. 2019 Apr 23. pii: S0264-410X(19)30511.
    PubMed     Text format     Abstract available


  38. HUERTAS-DIAZ MC, Phan S, Elson A, Nunez I, et al
    Parainfluenza virus 5 (PIV5) amplifying virus-like particles expressing respiratory syncytial virus (RSV) antigens protect mice against RSV infection.
    Vaccine. 2019 Apr 19. pii: S0264-410X(19)30506.
    PubMed     Text format     Abstract available


  39. GRANICHER G, Coronel J, Pralow A, Marichal-Gallardo P, et al
    Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Vaccine. 2019 Apr 17. pii: S0264-410X(19)30481.
    PubMed     Text format     Abstract available


  40. POLAND GA, Hall LL, Powell JA
    Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation.
    Vaccine. 2019;37:2167-2170.
    PubMed     Text format    


  41. GENTILE A, Paget J, Bellei N, Torres JP, et al
    Influenza in Latin America: A report from the Global Influenza Initiative (GII).
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30436.
    PubMed     Text format     Abstract available


  42. EL SAHLY HM, Atmar RL, Patel SM, Bellamy A, et al
    Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30420.
    PubMed     Text format     Abstract available


  43. PADILLA-QUIRARTE HO, Badillo-Godinez O, Gutierrez-Xicotencatl L, Acevedo-Betancur Y, et al
    Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30257.
    PubMed     Text format     Abstract available


  44. HAVERI A, Ikonen N, Kantele A, Anttila VJ, et al
    Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Vaccine. 2019 Apr 3. pii: S0264-410X(19)30427.
    PubMed     Text format     Abstract available


  45. REGAN AK, Fielding JE, Chilver MB, Carville KS, et al
    Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Vaccine. 2019 Apr 2. pii: S0264-410X(19)30222.
    PubMed     Text format     Abstract available


    March 2019
  46. SAWLWIN DC, Graves Jones A, Albano FR
    Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30390.
    PubMed     Text format     Abstract available


  47. CASHMAN P, Moberley S, Chee K, Stephenson J, et al
    Participant centred safety surveillance of health care workers receiving influenza vaccination.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30320.
    PubMed     Text format     Abstract available


  48. ARNOLD LD, Luong L, Rebmann T, Chang JJ, et al
    Racial disparities in U.S. maternal influenza vaccine uptake: Results from analysis of Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2012-2015.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30208.
    PubMed     Text format     Abstract available


  49. ANDRES C, Peremiquel-Trillas P, Gimferrer L, Pinana M, et al
    Molecular influenza surveillance at a tertiary university hospital during four consecutive seasons (2012-2016) in Catalonia, Spain.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30380.
    PubMed     Text format     Abstract available


  50. EVERETT HE, Aramouni M, Coward V, Ramsay A, et al
    Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
    Vaccine. 2019 Mar 23. pii: S0264-410X(19)30316.
    PubMed     Text format     Abstract available


  51. TING-HUI-LIN, Chia MY, Lin CY, Yeh YQ, et al
    Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
    Vaccine. 2019;37:1897-1903.
    PubMed     Text format     Abstract available


  52. CRIADO MF, Bertran K, Lee DH, Killmaster L, et al
    Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30314.
    PubMed     Text format     Abstract available


  53. NORMAN DA, Danchin M, Van Buynder P, Moore HC, et al
    Caregiver's attitudes, beliefs, and experiences for influenza vaccination in Australian children with medical comorbidities.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30315.
    PubMed     Text format     Abstract available


  54. SCHAFFER SJ, Rand CM, Humiston SG, Concannon C, et al
    Practical considerations in developing a successful school-located influenza vaccination (SLIV) program.
    Vaccine. 2019 Mar 13. pii: S0264-410X(19)30290.
    PubMed     Text format    


  55. THORRINGTON D, van Leeuwen E, Ramsay M, Pebody R, et al
    Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30293.
    PubMed     Text format     Abstract available


  56. SEKIYA T, Mifsud EJ, Ohno M, Nomura N, et al
    Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30264.
    PubMed     Text format     Abstract available


  57. PAN SC, Hsieh SM, Lin CF, Hsu YS, et al
    A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(alphaK): A phase I study.
    Vaccine. 2019 Mar 2. pii: S0264-410X(19)30189.
    PubMed     Text format     Abstract available


  58. AINSLIE KEC, Haber M, Orenstein WA
    Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Vaccine. 2019 Mar 1. pii: S0264-410X(19)30241.
    PubMed     Text format     Abstract available


    February 2019
  59. GIDUTHURI JG, Purohit V, Maire N, Kudale A, et al
    Influenza vaccination of pregnant women: Engaging clinicians to reduce missed opportunities for vaccination.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30240.
    PubMed     Text format     Abstract available


  60. ZHANG D, Zhang Y, Wang Q, Lock J, et al
    The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30207.
    PubMed     Text format     Abstract available


  61. MEYER SB, Violette R, Aggarwal R, Simeoni M, et al
    Vaccine hesitancy and Web 2.0: Exploring how attitudes and beliefs about influenza vaccination are exchanged in online threaded user comments.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30223.
    PubMed     Text format     Abstract available


  62. GETAHUN D, Fassett MJ, Peltier MR, Takhar HS, et al
    Association between seasonal influenza vaccination with pre- and postnatal outcomes.
    Vaccine. 2019 Feb 21. pii: S0264-410X(19)30214.
    PubMed     Text format     Abstract available


  63. WANG Z, Li Z, Su X, Qiao Y, et al
    Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30206.
    PubMed     Text format     Abstract available


  64. WANG SH, Smith D, Cao Z, Chen J, et al
    Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
    Vaccine. 2019 Feb 19. pii: S0264-410X(19)30168.
    PubMed     Text format     Abstract available


  65. ABUBAKAR A, Melhem N, Malik M, Dbaibo G, et al
    Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.
    Vaccine. 2019 Feb 19. pii: S0264-410X(19)30163.
    PubMed     Text format     Abstract available


  66. DUROUS L, Julien T, Padey B, Traversier A, et al
    SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
    Vaccine. 2019 Feb 14. pii: S0264-410X(19)30181.
    PubMed     Text format     Abstract available


  67. ZENG Y, Yuan Z, Yin J, Han Y, et al
    Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30156.
    PubMed     Text format     Abstract available


  68. CHAE W, Kim P, Hwang BJ, Seong BL, et al
    Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30153.
    PubMed     Text format     Abstract available


  69. HERRERA-RODRIGUEZ J, Signorazzi A, Holtrop M, de Vries-Idema J, et al
    Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30184.
    PubMed     Text format     Abstract available


  70. PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
    Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30144.
    PubMed     Text format     Abstract available


  71. YOUNG-XU Y, Snider JT, van Aalst R, Mahmud SM, et al
    Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30148.
    PubMed     Text format     Abstract available


  72. HABER P, Moro PL, Ng C, Dores GM, et al
    Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30128.
    PubMed     Text format     Abstract available


  73. PETRIE JG, Martin ET, Truscon R, Johnson E, et al
    Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30131.
    PubMed     Text format     Abstract available


  74. BORGEY F, Henry L, Lebeltel J, Lescure P, et al
    Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30151.
    PubMed     Text format     Abstract available


  75. RAO S, Alishahi M, De Crescenzo L, Dempsey AF, et al
    A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016.
    Vaccine. 2019 Feb 2. pii: S0264-410X(19)30130.
    PubMed     Text format     Abstract available


    January 2019
  76. SHAPIRO JR, Hodgins B, Hendin HE, Patel A, et al
    Needle-free delivery of influenza vaccine using the Med-Jet(R) H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30103.
    PubMed     Text format     Abstract available


  77. GHORBANI A, Ngunjiri JM, Xia M, Elaish M, et al
    Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30100.
    PubMed     Text format     Abstract available


  78. SAHIN Z, Neeleman R, Haines J, Kayser V, et al
    Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30050.
    PubMed     Text format     Abstract available


  79. LU J, Luo M, Yee AZH, Sheldenkar A, et al
    Do superstitious beliefs affect influenza vaccine uptake through shaping health beliefs?
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30071.
    PubMed     Text format     Abstract available


  80. YUNG BS, Pugh H, Generotti AA, Phanhthilath N, et al
    Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30037.
    PubMed     Text format     Abstract available


  81. STRIJBOS E, Tannemaat MR, Alleman I, de Meel RHP, et al
    A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
    Vaccine. 2019 Jan 16. pii: S0264-410X(19)30038.
    PubMed     Text format     Abstract available


  82. BOCCALINI S, Tacconi FM, Lai PL, Bechini A, et al
    Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30026.
    PubMed     Text format     Abstract available


  83. MOOIJ P, Grodeland G, Koopman G, Andersen TK, et al
    Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.
    Vaccine. 2019 Jan 9. pii: S0264-410X(19)30005.
    PubMed     Text format     Abstract available


  84. MORAN A, Agaliotis M, Seale H
    The views of key stakeholders around mandatory influenza vaccination of hospital and aged care staff: Examining the current climate in Australia.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31702.
    PubMed     Text format     Abstract available


  85. PRASERT K, Patumanond J, Praphasiri P, Siriluk S, et al
    Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
    Vaccine. 2019 Jan 4. pii: S0264-410X(19)30003.
    PubMed     Text format     Abstract available


  86. WEHBI NK, Wani RJ, Klepser DG, Murry J, et al
    Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
    Vaccine. 2019;37:56-60.
    PubMed     Text format     Abstract available


    December 2018
  87. REGAN AK, Gibbs R, Bloomfield L, Effler PV, et al
    Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records.
    Vaccine. 2018 Dec 29. pii: S0264-410X(18)31651.
    PubMed     Text format     Abstract available


  88. PEPIN S, Dupuy M, Borja-Tabora CFC, Montellano M, et al
    Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.
    Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637.
    PubMed     Text format     Abstract available


  89. MILLER PDE, de Silva TI, Leonard H, Anthias C, et al
    A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoieti
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31586.
    PubMed     Text format     Abstract available


  90. KIMOTO T, Kim H, Sakai S, Takahashi E, et al
    Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity i
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31647.
    PubMed     Text format     Abstract available


  91. OSHANSKY CM, Zhou J, Gao Y, Schweinle JE, et al
    Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
    Vaccine. 2018 Dec 12. pii: S0264-410X(18)31632.
    PubMed     Text format     Abstract available


  92. CATTAPAN A, Browne K, Halperin DM, Di Castri A, et al
    Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Vaccine. 2018 Dec 6. pii: S0264-410X(18)31527.
    PubMed     Text format     Abstract available


    November 2018
  93. BRESEE JS, McKinlay MA, Abramson J, Klugman KP, et al
    Global Funders Consortium for Universal Influenza Vaccine Development.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31560.
    PubMed     Text format    


  94. DAWA J, Chaves SS, Ba Nguz A, Kalani R, et al
    Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31587.
    PubMed     Text format     Abstract available


  95. VAJO Z, Kalabay L, Vajo P, Balaton G, et al
    Licensing the first reduced, 6microg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31562.
    PubMed     Text format     Abstract available


  96. RIDDELL CA, Bhat N, Bont LJ, Dupont WD, et al
    Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31407.
    PubMed     Text format     Abstract available


  97. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
    Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31573.
    PubMed     Text format     Abstract available


  98. STEAD M, Critchlow N, Eadie D, Sullivan F, et al
    Mandatory policies for influenza vaccination: Views of managers and healthcare workers in England.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31556.
    PubMed     Text format     Abstract available


  99. TUCKERMAN J, Misan S, Salih S, Joseph Xavier B, et al
    Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31299.
    PubMed     Text format     Abstract available


  100. BIELECKI K, Kirolos A, Willocks LJ, Pollock KG, et al
    Low uptake of nasal influenza vaccine in polish and other ethnic minority children in Edinburgh, Scotland.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31552.
    PubMed     Text format     Abstract available


  101. YUE X, Black CL, Williams WW, Lu PJ, et al
    Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31499.
    PubMed     Text format     Abstract available


  102. WON SY, Hunt K, Guak H, Hasaj B, et al
    Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31496.
    PubMed     Text format     Abstract available


  103. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between patient reminders and influenza vaccination status among children.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31395.
    PubMed     Text format     Abstract available


  104. SHANG M, Chung JR, Jackson ML, Jackson LA, et al
    Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31490.
    PubMed     Text format     Abstract available


  105. MUNOZ FM, Jackson LA, Swamy GK, Edwards KM, et al
    Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31475.
    PubMed     Text format     Abstract available


  106. WILCOX CR, Bottrell K, Paterson P, Schulz WS, et al
    Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.
    Vaccine. 2018 Nov 3. pii: S0264-410X(18)31489.
    PubMed     Text format     Abstract available


    October 2018
  107. AHMED N, Quinn SC, Hancock GR, Freimuth VS, et al
    Social media use and influenza vaccine uptake among White and African American adults.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31415.
    PubMed     Text format     Abstract available


  108. GILBERT BE, Patel N, Lu H, Liu Y, et al
    Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31458.
    PubMed     Text format     Abstract available


  109. KRAMER R, Duclos A, Lina B, Casalegno JS, et al
    Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France.
    Vaccine. 2018;36:6591-6593.
    PubMed     Text format     Abstract available


  110. BEKKAT-BERKANI R, Romano-Mazzotti L
    Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31393.
    PubMed     Text format     Abstract available


  111. ZHAI Y, Santibanez TA, Kahn KE, Black CL, et al
    Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers.
    Vaccine. 2018 Oct 22. pii: S0264-410X(18)31405.
    PubMed     Text format     Abstract available


  112. DANCHIN MH, Costa-Pinto J, Attwell K, Willaby H, et al
    Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake.
    Vaccine. 2018;36:6473-6479.
    PubMed     Text format     Abstract available


  113. VAUGHN AR, Johnson ML
    Communicating and enhancing teachers' attitudes and understanding of influenza using refutational text.
    Vaccine. 2018 Oct 17. pii: S0264-410X(18)31406.
    PubMed     Text format     Abstract available


  114. WANG Q, Yue N, Zheng M, Wang D, et al
    Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411.
    PubMed     Text format     Abstract available


  115. D'ALESSIO F, Koopman G, Houard S, Remarque EJ, et al
    Workshop report: Experimental animal models for universal influenza vaccines.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31390.
    PubMed     Text format     Abstract available


  116. SANTIBANEZ TA, Kahn KE, Bridges CB
    Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31408.
    PubMed     Text format     Abstract available


  117. ZHANG L, Durr E, Galli JD, Cosmi S, et al
    Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
    PubMed     Text format     Abstract available


  118. THANG HV, Huong VM, Victor JC, Van CB, et al
    Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365.
    PubMed     Text format     Abstract available


  119. TOKARS JI, Rolfes MA, Foppa IM, Reed C, et al
    An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31392.
    PubMed     Text format     Abstract available


  120. YEOLEKAR LR, Ganguly M, Tyagi P, Ingle NB, et al
    Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Vaccine. 2018 Oct 12. pii: S0264-410X(18)31354.
    PubMed     Text format     Abstract available


  121. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
    Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
    PubMed     Text format     Abstract available


  122. BARTSCH SM, Taitel MS, DePasse JV, Cox SN, et al
    Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31300.
    PubMed     Text format     Abstract available


  123. TSUZUKI S, Schwehm M, Eichner M
    Corrigendum to "Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination" [Vaccine 36 (2018) 624-630].
    Vaccine. 2018 Oct 3. pii: S0264-410X(18)31315.
    PubMed     Text format    


  124. ROBISON SG, Thomas AR
    Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Vaccine. 2018 Oct 1. pii: S0264-410X(18)31319.
    PubMed     Text format     Abstract available


  125. GREEN CA, Sande CJ, de Lara C, Thompson AJ, et al
    Humoral and cellular immunity to RSV in infants, children and adults.
    Vaccine. 2018;36:6183-6190.
    PubMed     Text format     Abstract available


    September 2018
  126. BORG K, Sutton K, Beasley M, Tull F, et al
    Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial.
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31269.
    PubMed     Text format     Abstract available


  127. HAYASHI T, Lynch HE, Geyer S, Yoshida K, et al
    Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.
    Vaccine. 2018 Sep 28. pii: S0264-410X(18)31323.
    PubMed     Text format     Abstract available


  128. MOMOSE H, Sasaki E, Kuramitsu M, Hamaguchi I, et al
    Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.
    Vaccine. 2018 Sep 19. pii: S0264-410X(18)31270.
    PubMed     Text format     Abstract available


  129. BERTRAN K, Lee DH, Criado MF, Balzli CL, et al
    Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31264.
    PubMed     Text format     Abstract available


  130. DEDIEGO ML, Chiem K, Topham DJ
    Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31240.
    PubMed     Text format     Abstract available


  131. DIALLO A, Victor JC, Feser J, Ortiz JR, et al
    Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31158.
    PubMed     Text format     Abstract available


  132. GAGNON A, Acosta E, Miller MS
    Reporting and evaluating influenza virus surveillance data: An argument for incidence by single year of age.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31227.
    PubMed     Text format    


  133. MCGRATH LJ, Layton JB, Krueger WS, Kshirsagar AV, et al
    High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31229.
    PubMed     Text format     Abstract available


  134. WESTRICK SC, Patterson BJ, Kader MS, Rashid S, et al
    National survey of pharmacy-based immunization services.
    Vaccine. 2018;36:5657-5664.
    PubMed     Text format     Abstract available


  135. MORGENSTERN K, Xie Y, Palladino G, Barr JR, et al
    Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31204.
    PubMed     Text format     Abstract available


  136. TAM YH, Ng TWY, Chu DKW, Fang VJ, et al
    The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31215.
    PubMed     Text format     Abstract available


  137. SOUZA CK, Rajao DS, Sandbulte MR, Lopes S, et al
    The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31212.
    PubMed     Text format     Abstract available


  138. MOMBELLI M, Rettby N, Perreau M, Pascual M, et al
    Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31186.
    PubMed     Text format     Abstract available


    August 2018
  139. CHIU HT, Shen LJ, Chen YC, Lin JH, et al
    Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly.
    Vaccine. 2018 Aug 30. pii: S0264-410X(18)31206.
    PubMed     Text format     Abstract available


  140. WHITAKER JA, von Itzstein MS, Poland GA
    Strategies to maximize influenza vaccine impact in older adults.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31169.
    PubMed     Text format     Abstract available


  141. STONE K, Akpalu Y, Horney J
    Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31139.
    PubMed     Text format     Abstract available


  142. NEWALL AT, Chen C, Wood JG, Stockwell MS, et al
    Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31114.
    PubMed     Text format     Abstract available


  143. WEIBEL D, Sturkenboom M, Black S, de Ridder M, et al
    Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31115.
    PubMed     Text format     Abstract available


  144. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  145. SHINJOH M, Sugaya N, Yamaguchi Y, Iibuchi N, et al
    Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
    Vaccine. 2018 Aug 6. pii: S0264-410X(18)31074.
    PubMed     Text format     Abstract available


  146. WU S, Pan Y, Zhang X, Zhang L, et al
    Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31097.
    PubMed     Text format     Abstract available


  147. YEUNG KHT, Tarrant M, Chan KCC, Tam WH, et al
    Increasing influenza vaccine uptake in children: A randomised controlled trial.
    Vaccine. 2018 Aug 2. pii: S0264-410X(18)31075.
    PubMed     Text format     Abstract available


  148. THOMPSON MG, Pierse N, Sue Huang Q, Prasad N, et al
    Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Vaccine. 2018 Aug 1. pii: S0264-410X(18)30997.
    PubMed     Text format     Abstract available


    July 2018
  149. ORTQVIST A, Brytting M, Leval A, Hergens MP, et al
    Impact of repeated influenza vaccinations in persons over 65years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31046.
    PubMed     Text format     Abstract available


  150. NOH JY, Choi WS, Song JY, Lee HS, et al
    Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
    PubMed     Text format     Abstract available


  151. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
    PubMed     Text format     Abstract available


  152. FORD AJ, Alwan NA
    Use of social networking sites and women's decision to receive vaccinations during pregnancy: A cross-sectional study in the UK.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30988.
    PubMed     Text format     Abstract available


  153. FERDMAN J, Palladino G, Liao HX, Moody MA, et al
    Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59(R)-adjuvanted pandemic 2009 H1N1 vaccine.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30895.
    PubMed     Text format     Abstract available


  154. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
    Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
    PubMed     Text format     Abstract available


  155. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Text format     Abstract available


  156. MAKARKOV AI, Patel AR, Bainov V, Ward BJ, et al
    A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.
    Vaccine. 2018;36:4485-4493.
    PubMed     Text format     Abstract available


  157. ZHANG L, Pan Y, Hackert V, van der Hoek W, et al
    The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30947.
    PubMed     Text format     Abstract available


  158. HATTA Y, Boltz D, Sarawar S, Kawaoka Y, et al
    Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Vaccine. 2018 Jul 12. pii: S0264-410X(18)30894.
    PubMed     Text format     Abstract available


  159. HARRISON N, Poeppl W, Miksch M, Machold K, et al
    Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30906.
    PubMed     Text format     Abstract available


    June 2018
  160. BRADY RC, Jackson LA, Frey SE, Shane AL, et al
    Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
    Vaccine. 2018 Jun 28. pii: S0264-410X(18)30864.
    PubMed     Text format     Abstract available


  161. PING X, Hu W, Xiong R, Zhang X, et al
    Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.
    Vaccine. 2018 Jun 27. pii: S0264-410X(18)30889.
    PubMed     Text format     Abstract available


  162. SCHLAUDECKER EP, Ambroggio L, McNeal MM, Finkelman FD, et al
    Declining responsiveness to influenza vaccination with progression of human pregnancy.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30796.
    PubMed     Text format     Abstract available


  163. SCHELTEMA NM, Kavelaars XM, Thorburn K, Hennus MP, et al
    Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30837.
    PubMed     Text format     Abstract available


  164. DAI X, Li N, Roller RJ
    Peroxiredoxin 1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus replication.
    Vaccine. 2018 Jun 16. pii: S0264-410X(18)30823.
    PubMed     Text format     Abstract available


  165. ORTIZ JR
    Implementation of maternal influenza immunization programs.
    Vaccine. 2018;36:3571.
    PubMed     Text format    


  166. KOUL PA, Mir H
    The biggest barrier to influenza vaccination in pregnant females in India: Poor sensitization of the care providers.
    Vaccine. 2018;36:3569-3570.
    PubMed     Text format    


  167. SHEN AK, Warnock R, Chu S, Kelman JA, et al
    Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30836.
    PubMed     Text format     Abstract available


  168. STRASSBERG ER, Power M, Schulkin J, Stark LM, et al
    Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30800.
    PubMed     Text format     Abstract available


  169. ENGELHARDT OG, Edge C, Dunleavy U, Guilfoyle K, et al
    Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30742.
    PubMed     Text format     Abstract available


  170. JOYCE C, Scallan CD, Mateo R, Belshe RB, et al
    Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30789.
    PubMed     Text format     Abstract available


  171. VALKENBURG SA, Li OTW, Li A, Bull M, et al
    Protection by universal influenza vaccine is mediated by memory CD4 T cells.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30818.
    PubMed     Text format     Abstract available


  172. FAN X, Su Q, Qiu F, Yi Y, et al
    Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30739.
    PubMed     Text format     Abstract available


  173. HENDRIKS J, Hutubessy RCW, Grohmann G, Torelli G, et al
    Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
    Vaccine. 2018 Jun 1. pii: S0264-410X(18)30766.
    PubMed     Text format     Abstract available


    May 2018
  174. GARRETSON TA, Petrie JG, Martin ET, Monto AS, et al
    Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30752.
    PubMed     Text format     Abstract available


  175. FLEMING JA, Baltrons R, Rowley E, Quintanilla I, et al
    Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30762.
    PubMed     Text format     Abstract available


  176. ZHANG W, Sun H, Atiquzzaman M, Sou J, et al
    Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30743.
    PubMed     Text format     Abstract available


  177. ASTILL J, Alkie T, Yitbarek A, Abdelaziz KTA, et al
    Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Vaccine. 2018 May 28. pii: S0264-410X(18)30759.
    PubMed     Text format     Abstract available


  178. PUTRI WCWS, Muscatello DJ, Stockwell MS, Newall AT, et al
    Economic burden of seasonal influenza in the United States.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30677.
    PubMed     Text format     Abstract available


  179. LOGAN J, Nederhoff D, Koch B, Griffith B, et al
    'What have you HEARD about the HERD?' Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?
    Vaccine. 2018 May 19. pii: S0264-410X(18)30657.
    PubMed     Text format     Abstract available


  180. YANG YT, Silverman RD
    Mandatory influenza vaccination and religious accommodation for healthcare workers: Lessons from recent legal challenges.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30714.
    PubMed     Text format    


  181. FERNANDO GJP, Hickling J, Jayashi Flores CM, Griffin P, et al
    Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch).
    Vaccine. 2018 May 17. pii: S0264-410X(18)30673.
    PubMed     Text format     Abstract available


  182. GRIEVES JL, Yin Z, Garcia-Sastre A, Mena I, et al
    A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
    Vaccine. 2018 May 17. pii: S0264-410X(18)30609.
    PubMed     Text format     Abstract available


  183. JAIN S, George PJ, Deng W, Koussa J, et al
    The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4(+) T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30636.
    PubMed     Text format     Abstract available


  184. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between provider recommendation and influenza vaccination status among children.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30584.
    PubMed     Text format     Abstract available


  185. HARRISON SM, Wei MY, Lamerato LE, Petrie JG, et al
    Multimorbidity is associated with uptake of influenza vaccination.
    Vaccine. 2018 May 7. pii: S0264-410X(18)30628.
    PubMed     Text format     Abstract available


  186. ARRIOLA CS, Vasconez N, Bresee J, Ropero AM, et al
    "Knowledge, attitudes and practices about influenza vaccination among pregnant women and healthcare providers serving pregnant women in Managua, Nicaragua".
    Vaccine. 2018 May 7. pii: S0264-410X(18)30620.
    PubMed     Text format     Abstract available


  187. SEO J, Lim J
    Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: Effect of public health policies on vaccination behavior.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30631.
    PubMed     Text format     Abstract available


  188. YEUNG KHT, Chan KCC, Chan PKS, Lam DSY, et al
    Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30588.
    PubMed     Text format     Abstract available


  189. BARTOSZKO JJ, McNamara IF, Aras OAZ, Hylton DA, et al
    Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
    Vaccine. 2018 May 1. pii: S0264-410X(18)30546.
    PubMed     Text format     Abstract available


    April 2018
  190. BOEY L, Bral C, Roelants M, De Schryver A, et al
    Attitudes, believes, determinants and organisational barriers behind the low seasonal influenza vaccination uptake in healthcare workers - A cross-sectional survey.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30539.
    PubMed     Text format     Abstract available


  191. TESSIER E, Warburton F, Tsang C, Rafeeq S, et al
    Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30581.
    PubMed     Text format     Abstract available


  192. REGAN AK, Gibbs RA, Effler PV
    An audit of the reliability of influenza vaccination and medical information extracted from eHealth records in general practice.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30583.
    PubMed     Text format     Abstract available


  193. SOMES MP, Turner RM, Dwyer LJ, Newall AT, et al
    Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30560.
    PubMed     Text format     Abstract available


  194. VAN DE WITTE S, Nauta J, Montomoli E, Weckx J, et al
    A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    Vaccine. 2018 Apr 27. pii: S0264-410X(18)30538.
    PubMed     Text format     Abstract available


  195. LI R, Xie R, Yang C, Rainey J, et al
    Identifying ways to increase seasonal influenza vaccine uptake among pregnant women in China: A qualitative investigation of pregnant women and their obstetricians.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30557.
    PubMed     Text format     Abstract available


  196. HJERTNER B, Bengtsson T, Morein B, Paulie S, et al
    A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30551.
    PubMed     Text format     Abstract available


  197. OHLROGGE AW, Suggs LS
    Flu vaccination communication in Europe: What does the government communicate and how?
    Vaccine. 2018 Apr 24. pii: S0264-410X(18)30525.
    PubMed     Text format     Abstract available


  198. KUCK LR, Byrne-Nash R, Gillis J, Bueter K, et al
    VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30545.
    PubMed     Text format     Abstract available


  199. DALE LP, White L, Mitchell M, Faulkner G, et al
    Smartphone app uses loyalty point incentives and push notifications to encourage influenza vaccine uptake.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30487.
    PubMed     Text format     Abstract available


  200. VERHEES RAF, Dondorp W, Thijs C, Dinant GJ, et al
    Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30510.
    PubMed     Text format     Abstract available


  201. SUZUKI M, Katsurada N, Le MN, Kaneko N, et al
    Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged >/=65years in Japan.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30520.
    PubMed     Text format     Abstract available



  202. Response to three Letters to the Editor regarding: Donahue JG, et al. "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12". Vaccine 35 (2017) 5314-5322.
    Vaccine. 2018;36:2231-2232.
    PubMed     Text format    


  203. SARKAR I, Garg R, van Drunen Littel-van den Hurk S
    The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
    Vaccine. 2018;36:2326-2336.
    PubMed     Text format     Abstract available


  204. AULT KA, Riley LE
    Response to Donahue et al. 2017 in press article.
    Vaccine. 2018;36:2230.
    PubMed     Text format    


  205. WEN Y, Palladino G, Xie Y, Ferrari A, et al
    Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30490.
    PubMed     Text format     Abstract available


  206. HOSCHLER K, Southern J, Thompson C, Warburton F, et al
    Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30486.
    PubMed     Text format     Abstract available


  207. SZILAGYI PG, Schaffer S, Rand CM, Goldstein NPN, et al
    Impact of elementary school-located influenza vaccinations: A stepped wedge trial across a community.
    Vaccine. 2018 Apr 17. pii: S0264-410X(18)30403.
    PubMed     Text format     Abstract available


  208. SHIBATA N, Kimura S, Hoshino T, Takeuchi M, et al
    Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30460.
    PubMed     Text format     Abstract available


  209. BISSET KA, Paterson P
    Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30482.
    PubMed     Text format     Abstract available


  210. HOFFMANN A, Dumke C, Hanschmann KO, Wicker S, et al
    Local thermal reaction after influenza vaccination: Quantification by infrared imaging and biometric considerations.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30467.
    PubMed     Text format     Abstract available


  211. LAPUENTE D, Ruzsics Z, Thirion C, Tenbusch M, et al
    Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30262.
    PubMed     Text format     Abstract available


  212. DABAGHIAN M, Latifi AM, Tebianian M, NajmiNejad H, et al
    Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30259.
    PubMed     Text format     Abstract available


  213. CONLIN AMS, Bukowinski AT, Levine JA, Khodr ZG, et al
    A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30417.
    PubMed     Text format     Abstract available


    March 2018
  214. ESPOSITO S, Franco E, Gavazzi G, de Miguel AG, et al
    The public health value of vaccination for seniors in Europe.
    Vaccine. 2018 Mar 31. pii: S0264-410X(18)30409.
    PubMed     Text format     Abstract available


  215. WENDLANDT R, Cowling BJ, Chen Y, Havers F, et al
    Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China.
    Vaccine. 2018 Mar 29. pii: S0264-410X(18)30408.
    PubMed     Text format     Abstract available


  216. KASSIANOS G, Kuchar E, Nitsch-Osuch A, Kyncl J, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30205.
    PubMed     Text format     Abstract available


  217. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30382.
    PubMed     Text format     Abstract available


  218. CITRON MP, Patel M, Purcell M, Lin SA, et al
    A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
    Vaccine. 2018 Mar 26. pii: S0264-410X(18)30320.
    PubMed     Text format     Abstract available


  219. KRETZSCHMAR E, Muckenfuss H, Pfleiderer M
    Official batch control of influenza vaccines: Is it still useful?
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30275.
    PubMed     Text format     Abstract available


  220. WANG Y, Chen L, Yu J, Pang Y, et al
    The effectiveness of influenza vaccination among nursery school children in China during the 2016/17 influenza season.
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30384.
    PubMed     Text format     Abstract available


  221. ALFELALI M, Barasheed O, Badahdah AM, Bokhary H, et al
    Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30343.
    PubMed     Text format     Abstract available


  222. SOEDJATMIKO S, Medise BE, Gunardi H, Sekartini R, et al
    Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.
    Vaccine. 2018 Mar 15. pii: S0264-410X(18)30324.
    PubMed     Text format     Abstract available


  223. LINDSAY BJ, Bonar MM, Costas-Cancelas IN, Hunt K, et al
    Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
    Vaccine. 2018 Mar 14. pii: S0264-410X(18)30316.
    PubMed     Text format     Abstract available


  224. NICHOLS MK, Andrew MK, Hatchette TF, Ambrose A, et al
    Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30292.
    PubMed     Text format     Abstract available


  225. KESHTKAR-JAHROMI M, Ouyang M, Keshtkarjahromi M, Almed S, et al
    Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.
    Vaccine. 2018 Mar 13. pii: S0264-410X(17)31609.
    PubMed     Text format     Abstract available


  226. TETE SM, Jul-Larsen A, Rostami S, Lunde THF, et al
    Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30196.
    PubMed     Text format     Abstract available


  227. RIKIN S, Jia H, Vargas CY, Castellanos de Belliard Y, et al
    Assessment of temporally-related acute respiratory illness following influenza vaccination.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30315.
    PubMed     Text format     Abstract available


  228. SUNDARAM N, Duckett K, Yung CF, Thoon KC, et al
    "I wouldn't really believe statistics" - Challenges with influenza vaccine acceptance among healthcare workers in Singapore.
    Vaccine. 2018 Mar 5. pii: S0264-410X(18)30312.
    PubMed     Text format     Abstract available


  229. SURTEES TC, Teh BW, Slavin MA, Worth LJ, et al
    Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30297.
    PubMed     Text format     Abstract available


  230. CZAKO R, Vogel L, Sutton T, Matsuoka Y, et al
    H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30248.
    PubMed     Text format     Abstract available


    February 2018
  231. ARMITAGE EP, Camara J, Bah S, Forster AS, et al
    Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.
    Vaccine. 2018 Feb 23. pii: S0264-410X(18)30211.
    PubMed     Text format     Abstract available


  232. WESTCOTT MM, Clemens EA, Holbrook BC, King SB, et al
    The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells.
    Vaccine. 2018;36:1174-1182.
    PubMed     Text format     Abstract available


  233. KING JP, McLean HQ, Meece JK, Levine MZ, et al
    Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    Vaccine. 2018;36:1214-1219.
    PubMed     Text format     Abstract available


  234. WHITE KM, Ayllon J, Mena I, Potenski A, et al
    Influenza B virus reverse genetic backbones with improved growth properties in the EB66(R) cell line as basis for vaccine seed virus generation.
    Vaccine. 2018;36:1146-1153.
    PubMed     Text format     Abstract available


  235. IBANEZ LI, Caldevilla CA, Paredes Rojas Y, Mattion N, et al
    Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30193.
    PubMed     Text format     Abstract available


  236. SYCHEVA AL, Pogorelyy MV, Komech EA, Minervina AA, et al
    Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30201.
    PubMed     Text format     Abstract available


  237. DJAGBARE MD, Yu L, Parupudi A, Sun J, et al
    Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30115.
    PubMed     Text format     Abstract available


  238. MAGIRI R, Lai K, Chaffey A, Zhou Y, et al
    Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30200.
    PubMed     Text format     Abstract available


  239. BAYER L, Fertey J, Ulbert S, Grunwald T, et al
    Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30188.
    PubMed     Text format     Abstract available


  240. PANDO R, Sharabi S, Mandelboim M
    Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter.
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30158.
    PubMed     Text format     Abstract available


  241. DE BEKKER-GROB EW, Veldwijk J, Jonker M, Donkers B, et al
    The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30103.
    PubMed     Text format     Abstract available


  242. RUSSELL K, Chung JR, Monto AS, Martin ET, et al
    Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
    Vaccine. 2018 Feb 2. pii: S0264-410X(18)30094.
    PubMed     Text format     Abstract available


    January 2018
  243. KAPLAN BS, Souza CK, Gauger PC, Stauft CB, et al
    Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30061.
    PubMed     Text format     Abstract available


  244. DE BOER PT, Kelso JK, Halder N, Nguyen TP, et al
    The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
    Vaccine. 2018 Jan 17. pii: S0264-410X(17)31836.
    PubMed     Text format     Abstract available


  245. MORIMOTO N, Takeishi K
    Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30057.
    PubMed     Text format     Abstract available


  246. SUGAYA N, Shinjoh M, Nakata Y, Tsunematsu K, et al
    Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30058.
    PubMed     Text format     Abstract available


  247. LU PJ, Srivastav A, Amaya A, Dever JA, et al
    Association of provider recommendation and offer and influenza vaccination among adults aged >/=18years - United States.
    Vaccine. 2018 Jan 9. pii: S0264-410X(17)31759.
    PubMed     Text format     Abstract available


  248. SHIM E, Smith KJ, Nowalk MP, Raviotta JM, et al
    Impact of seasonal influenza vaccination in the presence of vaccine interference.
    Vaccine. 2018 Jan 9. pii: S0264-410X(17)31830.
    PubMed     Text format     Abstract available


  249. BIEZEN R, Grando D, Mazza D, Brijnath B, et al
    Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers.
    Vaccine. 2018 Jan 5. pii: S0264-410X(17)31828.
    PubMed     Text format     Abstract available


  250. CISZEWSKI A
    Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
    Vaccine. 2018;36:202-206.
    PubMed     Text format     Abstract available


  251. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Text format     Abstract available


    December 2017
  252. TSUZUKI S, Schwehm M, Eichner M
    Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination.
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31819.
    PubMed     Text format     Abstract available


  253. JORGENSEN P, Mereckiene J, Cotter S, Johansen K, et al
    How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Vaccine. 2017 Dec 26. pii: S0264-410X(17)31762.
    PubMed     Text format     Abstract available


  254. ROECA C, Polotsky AJ
    Influenza vaccination in early pregnancy.
    Vaccine. 2017 Dec 21. pii: S0264-410X(17)31785.
    PubMed     Text format    


  255. GALLAGHER N, Jessop L, Sartaj M, Johnston J, et al
    Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17.
    Vaccine. 2017 Dec 21. pii: S0264-410X(17)31730.
    PubMed     Text format     Abstract available


  256. REGAN AK, Moore HC, Sullivan SG
    Does influenza vaccination during early pregnancy really increase the risk of miscarriage?
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31786.
    PubMed     Text format    


  257. MELIDOU A, Broberg E
    Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition cons
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31792.
    PubMed     Text format    


  258. JACKSON ML, Phillips CH, Benoit J, Kiniry E, et al
    The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31775.
    PubMed     Text format     Abstract available


  259. JACKSON ML, Phillips CH, Benoit J, Jackson LA, et al
    Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31755.
    PubMed     Text format     Abstract available


  260. FLOREK NW, Campos LM, Braun KM, McLean HQ, et al
    An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31777.
    PubMed     Text format     Abstract available


  261. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31676.
    PubMed     Text format     Abstract available


  262. WU S, Su J, Yang P, Zhang H, et al
    Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China.
    Vaccine. 2017 Dec 12. pii: S0264-410X(17)31746.
    PubMed     Text format     Abstract available


  263. RABENSTEINER A, Buja A, Regele D, Fischer M, et al
    Healthcare worker's attitude to seasonal influenza vaccination in the South Tyrolean province of Italy: barriers and facilitators.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31734.
    PubMed     Text format     Abstract available


  264. NUNN A, Campbell AC, Naus M, Kwong JC, et al
    Implementing a province-wide mandatory vaccinate-or-mask policy at healthcare facilities in British Columbia, Canada.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31713.
    PubMed     Text format     Abstract available


  265. ORTIZ JR, Hickling J, Jones R, Donabedian A, et al
    Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
    Vaccine. 2017 Dec 5. pii: S0264-410X(17)31645.
    PubMed     Text format     Abstract available


    November 2017
  266. RUSSELL KE, Bresee JS, Katz JM, Olsen SJ, et al
    Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.
    Vaccine. 2017 Nov 30. pii: S0264-410X(17)31536.
    PubMed     Text format     Abstract available


  267. BALZLI CL, Bertran K, Lee DH, Killmaster L, et al
    The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31590.
    PubMed     Text format     Abstract available


  268. LAPINSCKI B, Pereira LA, Nogueira MB, Vidal LR, et al
    Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31597.
    PubMed     Text format     Abstract available


  269. SHIN HY, Chung JH, Hwang HJ, Kim TH, et al
    Factors influencing on influenza vaccination and its trends of coverage in patients with diabetes in Korea: A population-based cross-sectional study.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31599.
    PubMed     Text format     Abstract available


  270. BOONNAK K, Dhitavat J, Thantamnu N, Kosoltanapiwat N, et al
    Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31538.
    PubMed     Text format     Abstract available


  271. MALOSH RE, Martin ET, Ortiz JR, Monto AS, et al
    The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31577.
    PubMed     Text format     Abstract available


  272. GARG R, Brownlie R, Latimer L, Gerdts V, et al
    Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Vaccine. 2017 Nov 16. pii: S0264-410X(17)31524.
    PubMed     Text format     Abstract available


  273. AINSLIE KEC, Shi M, Haber M, Orenstein WA, et al
    On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31539.
    PubMed     Text format     Abstract available


  274. COLE KS, Martin JM, Horne WT, Lin CJ, et al
    Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31235.
    PubMed     Text format     Abstract available


  275. ALBRIGHT K, Hurley LP, Lockhart S, Gurfinkel D, et al
    Attitudes about adult vaccines and reminder/recall in a safety net population.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31543.
    PubMed     Text format     Abstract available


  276. PAN Y, Wang Q, Yang P, Zhang L, et al
    Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31525.
    PubMed     Text format     Abstract available


  277. PUIG-BARBERA J, Guglieri-Lopez B, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31529.
    PubMed     Text format     Abstract available


  278. PILLSBURY A, Quinn H, Cashman P, Leeb A, et al
    Active SMS-based influenza vaccine safety surveillance in Australian children.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31499.
    PubMed     Text format     Abstract available


  279. CROUSE QUINN S, Jamison AM, Freimuth VS, An J, et al
    Determinants of influenza vaccination among high-risk Black and White adults.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31491.
    PubMed     Text format     Abstract available


  280. DIOS-GUERRA C, Carmona-Torres JM, Lopez-Soto PJ, Morales-Cane I, et al
    Prevalence and factors associated with influenza vaccination of persons over 65 years old in Spain (2009-2014).
    Vaccine. 2017 Nov 6. pii: S0264-410X(17)31494.
    PubMed     Text format     Abstract available


  281. MCELHANEY JE, Andrew MK, McNeil SA
    Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults.
    Vaccine. 2017;35:6269-6274.
    PubMed     Text format     Abstract available


    October 2017
  282. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31372.
    PubMed     Text format     Abstract available


  283. ROLFES MA, Goswami D, Sharmeen AT, Yeasmin S, et al
    Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31482.
    PubMed     Text format     Abstract available


  284. YAN J, Morrow MP, Chu JS, Racine T, et al
    Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31358.
    PubMed     Text format     Abstract available


  285. STOCKWELL MS, Marchant CD, Wodi AP, Barnett ED, et al
    A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31481.
    PubMed     Text format     Abstract available


  286. NG S, Saborio S, Kuan G, Gresh L, et al
    Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.
    Vaccine. 2017;35:6202-6207.
    PubMed     Text format     Abstract available


  287. NI Y, Guo J, Turner D, Tizard I, et al
    Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.
    Vaccine. 2017 Oct 25. pii: S0264-410X(17)31459.
    PubMed     Text format     Abstract available


  288. MORIYAMA M, Takeyama H, Hasegawa H, Ichinohe T, et al
    Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31446.
    PubMed     Text format     Abstract available


  289. WOHLGEMUTH N, Ye Y, Fenstermacher KJ, Liu H, et al
    The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31414.
    PubMed     Text format     Abstract available


  290. WALTER EB, Hornik CP, Grohskopf L, McGee CE, et al
    The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.
    Vaccine. 2017 Oct 19. pii: S0264-410X(17)31416.
    PubMed     Text format     Abstract available


  291. HU Z, Liu X, Jiao X, Liu X, et al
    Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31375.
    PubMed     Text format     Abstract available


  292. ORTIZ JR, Hombach J
    Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31226.
    PubMed     Text format     Abstract available


  293. PUIG-BARBERA J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015.
    Vaccine. 2017;35:5799-5807.
    PubMed     Text format     Abstract available


  294. OLATUNBOSUN OD, Esterhuizen TM, Wiysonge CS
    A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31370.
    PubMed     Text format     Abstract available


  295. HO HJ, Chan YY, Ibrahim MAB, Wagle AA, et al
    A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31369.
    PubMed     Text format     Abstract available


  296. ANA-SOSA-BATIZ F, Johnston APR, Hogarth PM, Wines BD, et al
    Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31315.
    PubMed     Text format     Abstract available


  297. OFORI-ANYINAM O, Leroux-Roels G, Drame M, Aerssens A, et al
    Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults >/=50years of age: Results from a phase III, randomized, non-i
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31228.
    PubMed     Text format     Abstract available


  298. SUN P, Crum-Cianflone NF, Defang G, Williams M, et al
    Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
    Vaccine. 2017 Oct 4. pii: S0264-410X(17)31307.
    PubMed     Text format     Abstract available


    September 2017
  299. FORERO A, Fenstermacher K, Wohlgemuth N, Nishida A, et al
    Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.
    Vaccine. 2017 Sep 28. pii: S0264-410X(17)31306.
    PubMed     Text format     Abstract available


  300. HOLBROOK BC, D'Agostino RB Jr, Tyler Aycock S, Jorgensen MJ, et al
    Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31302.
    PubMed     Text format     Abstract available


  301. HOGAN AB, Campbell PT, Blyth CC, Lim FJ, et al
    Potential impact of a maternal vaccine for RSV: A mathematical modelling study.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31272.
    PubMed     Text format     Abstract available


  302. CHAMBERS CD, Xu R, Mitchell AA
    Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12".
    Vaccine. 2017;35:5323-5324.
    PubMed     Text format    


  303. DONAHUE JG, Kieke BA, King JP, DeStefano F, et al
    Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.
    Vaccine. 2017;35:5314-5322.
    PubMed     Text format     Abstract available


  304. VALLEE-TOURANGEAU G, Promberger M, Moon K, Wheelock A, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: Development and validation of two short scales.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31092.
    PubMed     Text format     Abstract available


  305. KANDEIL A, Mostafa A, El-Shesheny R, El-Taweel AN, et al
    Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31269.
    PubMed     Text format     Abstract available


  306. HALSEY NA, Proveaux T
    Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31297.
    PubMed     Text format     Abstract available


  307. LOW MSF, Tan H, Hartman M, Tam CC, et al
    Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31308.
    PubMed     Text format     Abstract available


  308. ZIMMERMAN RK, Raviotta JM, Nowalk MP, Moehling KK, et al
    Using the 4 Pillars Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Vaccine. 2017 Sep 22. pii: S0264-410X(17)31268.
    PubMed     Text format     Abstract available


  309. PRINCIPI N, Esposito S
    Influenza vaccine use to protect healthy children: A debated topic.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31232.
    PubMed     Text format     Abstract available


  310. EATON A, Lewis N, Fireman B, Hansen J, et al
    Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31180.
    PubMed     Text format     Abstract available


  311. TAN S, Zhang S, Wu B, Zhao Y, et al
    Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31159.
    PubMed     Text format     Abstract available


  312. ISLAM S, Mohn KG, Krammer F, Sanne M, et al
    Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31132.
    PubMed     Text format     Abstract available


  313. NEUZIL KM, Bresee JS, de la Hoz F, Johansen K, et al
    Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31188.
    PubMed     Text format     Abstract available


  314. RAVIOTTA JM, Smith KJ, DePasse J, Brown ST, et al
    Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)30977.
    PubMed     Text format     Abstract available


  315. LUZ PM, Johnson RE, Brown HE
    Workplace availability, risk group and perceived barriers predictive of 2016-17 influenza vaccine uptake in the United States: A cross-sectional study.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31178.
    PubMed     Text format     Abstract available


  316. VICKERS ER, McClure DL, Naleway AL, Jacobsen SJ, et al
    Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31186.
    PubMed     Text format     Abstract available


  317. ADAMSON PJ, Al Kindi MA, Wang JJ, Colella AD, et al
    Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31151.
    PubMed     Text format     Abstract available


  318. WOO EJ, Moro PL, Cano M, Jankosky C, et al
    Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31135.
    PubMed     Text format     Abstract available


  319. SANTOS JJS, Obadan AO, Garcia SC, Carnaccini S, et al
    Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31157.
    PubMed     Text format     Abstract available


    August 2017
  320. FELL DB, Azziz-Baumgartner E, Baker MG, Batra M, et al
    Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.
    Vaccine. 2017 Aug 31. pii: S0264-410X(17)31125.
    PubMed     Text format     Abstract available


  321. SANO K, Ainai A, Suzuki T, Hasegawa H, et al
    The road to a more effective influenza vaccine: Up to date studies and future prospects.
    Vaccine. 2017 Aug 30. pii: S0264-410X(17)31118.
    PubMed     Text format     Abstract available


  322. WATKINS HC, Pagan CL, Childs HR, Posada S, et al
    A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles.
    Vaccine. 2017 Aug 30. pii: S0264-410X(17)31080.
    PubMed     Text format     Abstract available


  323. FUKUSHIMA W, Ozasa K, Okumura A, Mori M, et al
    Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?
    Vaccine. 2017;35:4817-4824.
    PubMed     Text format     Abstract available


  324. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Estimating influenza disease burden among pregnant women: Application of self-control method.
    Vaccine. 2017;35:4811-4816.
    PubMed     Text format     Abstract available


  325. KONDO K, Suzuki K, Washio M, Ohfuji S, et al
    Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
    Vaccine. 2017;35:4806-4810.
    PubMed     Text format     Abstract available


  326. FUKUSHIMA W, Hirota Y
    Basic principles of test-negative design in evaluating influenza vaccine effectiveness.
    Vaccine. 2017;35:4796-4800.
    PubMed     Text format     Abstract available


  327. HARA M, Hirota Y
    Basic principle of population-based cohort study to evaluate influenza vaccine effectiveness among elderly Japanese.
    Vaccine. 2017;35:4791-4795.
    PubMed     Text format     Abstract available


  328. HIROTA Y, Ozasa K, Nakano T
    Vaccine epidemiology: Its role in promoting sound immunization programs in Japan.
    Vaccine. 2017;35:4787-4790.
    PubMed     Text format     Abstract available


  329. LEVIN MJ, Buchwald UK, Gardner J, Martin J, et al
    Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Vaccine. 2017 Aug 19. pii: S0264-410X(17)31096.
    PubMed     Text format     Abstract available


  330. SMITH G, Liu Y, Flyer D, Massare MJ, et al
    Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Vaccine. 2017 Aug 18. pii: S0264-410X(17)31088.
    PubMed     Text format     Abstract available


  331. MCHUGH L, Andrews RM, Ware RS
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy 2012-2014: The FluMum study.
    Vaccine. 2017;35.
    PubMed     Text format    


  332. HUTCHEON J, Ortiz J
    Re: Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy 2012-2014: The FluMum study.
    Vaccine. 2017;35.
    PubMed     Text format    


  333. PATERSON P, Chantler T, Larson HJ
    Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school pilot programme in England.
    Vaccine. 2017 Aug 14. pii: S0264-410X(17)31083.
    PubMed     Text format     Abstract available


  334. D'ANGIO CT, Wyman CP, Misra RS, Halliley JL, et al
    Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants.
    Vaccine. 2017 Aug 11. pii: S0264-410X(17)31068.
    PubMed     Text format     Abstract available


  335. GOEIJENBIER M, van Sloten TT, Slobbe L, Mathieu C, et al
    Benefits of flu vaccination for persons with diabetes mellitus: A review.
    Vaccine. 2017 Aug 11. pii: S0264-410X(17)31021.
    PubMed     Text format     Abstract available


  336. ALLEN JD, Owino SO, Carter DM, Crevar CJ, et al
    Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines.
    Vaccine. 2017 Aug 5. pii: S0264-410X(17)31043.
    PubMed     Text format     Abstract available


  337. OHFUJI S, Kobayashi M, Ide Y, Egawa Y, et al
    Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine.
    Vaccine. 2017 Aug 4. pii: S0264-410X(17)31018.
    PubMed     Text format     Abstract available


  338. SUZUKI T, Ainai A, Hasegawa H
    Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)31019.
    PubMed     Text format     Abstract available


  339. MELIDOU A, Broberg E
    Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)30965.
    PubMed     Text format     Abstract available


  340. VILLANUEVA-CABEZAS JP, Coppo MJC, Durr PA, McVernon J, et al
    Vaccine efficacy against Indonesian Highly Pathogenic Avian Influenza H5N1: systematic review and meta-analysis.
    Vaccine. 2017 Aug 2. pii: S0264-410X(17)30967.
    PubMed     Text format     Abstract available


    July 2017
  341. PIERCE CL, Williams TL, Santana WI, Levine M, et al
    Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat.
    Vaccine. 2017 Jul 31. pii: S0264-410X(17)30957.
    PubMed     Text format     Abstract available


  342. BOIKOS C, Joseph L, Scheifele D, Lands LC, et al
    Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons.
    Vaccine. 2017 Jul 31. pii: S0264-410X(17)30976.
    PubMed     Text format     Abstract available


  343. YOON IS, Park H, Kwak HW, Woo Jung Y, et al
    Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis.
    Vaccine. 2017 Jul 28. pii: S0264-410X(17)30945.
    PubMed     Text format     Abstract available


  344. FOGEL B, Hicks S
    Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended.
    Vaccine. 2017 Jul 28. pii: S0264-410X(17)30975.
    PubMed     Text format     Abstract available


  345. AYORA-TALAVERA G, Flores GM, Gomez-Carballo J, Gonzalez-Losa R, et al
    Influenza seasonality goes south in the Yucatan Peninsula: The case for a different influenza vaccine calendar in this Mexican region.
    Vaccine. 2017 Jul 26. pii: S0264-410X(17)30916.
    PubMed     Text format     Abstract available


  346. PALACHE A, Abelin A, Hollingsworth R, Cracknell W, et al
    Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving infl
    Vaccine. 2017 Jul 25. pii: S0264-410X(17)30961.
    PubMed     Text format     Abstract available


  347. HOFSTETTER AM, Barrett A, Camargo S, Rosenthal SL, et al
    Text message reminders for vaccination of adolescents with chronic medical conditions: A randomized clinical trial.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30920.
    PubMed     Text format     Abstract available


  348. FISCHER LM, Wolff MW, Reichl U
    Purification of cell culture-derived influenza A virus via continuous anion exchange chromatography on monoliths.
    Vaccine. 2017 Jul 17. pii: S0264-410X(17)30894.
    PubMed     Text format     Abstract available


  349. MADAN A, Collins H, Sheldon E, Frenette L, et al
    Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.
    Vaccine. 2017 Jul 15. pii: S0264-410X(17)30909.
    PubMed     Text format     Abstract available


  350. MORCL T, Hurst BL, Tarbet EB
    Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
    Vaccine. 2017 Jul 14. pii: S0264-410X(17)30912.
    PubMed     Text format     Abstract available


  351. MAKARKOV AI, Chierzi S, Pillet S, Murai KK, et al
    Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.
    Vaccine. 2017 Jul 13. pii: S0264-410X(17)30908.
    PubMed     Text format     Abstract available


  352. FAGERLIN A, Valley TS, Scherer AM, Knaus M, et al
    Communicating infectious disease prevalence through graphics: Results from an international survey.
    Vaccine. 2017;35:4041-4047.
    PubMed     Text format     Abstract available


  353. RODRIGUEZ L, Nogales A, Murcia PR, Parrish CR, et al
    A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Vaccine. 2017 Jul 11. pii: S0264-410X(17)30857.
    PubMed     Text format     Abstract available


  354. RONDY M, Launay O, Castilla J, Costanzo S, et al
    Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Vaccine. 2017 Jul 11. pii: S0264-410X(17)30896.
    PubMed     Text format     Abstract available


  355. GOLDECK D, Theeten H, Hassouneh F, Oettinger L, et al
    Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine.
    Vaccine. 2017 Jul 6. pii: S0264-410X(17)30879.
    PubMed     Text format     Abstract available


  356. BELONGIA EA, Karron RA, Reingold A, Walter EB, et al
    The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.
    Vaccine. 2017 Jul 3. pii: S0264-410X(17)30794.
    PubMed     Text format    


  357. LU PJ, Srivastav A, Santibanez TA, Christopher Stringer M, et al
    Knowledge of influenza vaccination recommendation and early vaccination uptake during the 2015-16 season among adults aged >/=18years - United States.
    Vaccine. 2017 Jul 1. pii: S0264-410X(17)30871.
    PubMed     Text format     Abstract available


    June 2017
  358. VALDIN HL, Begue RE
    Influenza vaccines effectiveness 2013-14 through 2015-16, a test-negative study in children.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30847.
    PubMed     Text format     Abstract available


  359. SHI CR, Nambudiri VE
    Widespread psoriasis flare following influenza vaccination.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30864.
    PubMed     Text format    


  360. KIM SH, Samal SK
    Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30852.
    PubMed     Text format     Abstract available


  361. WU UI, Hsieh SM, Lee WS, Wang NC, et al
    Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30831.
    PubMed     Text format     Abstract available


  362. SONG Y, Zhang T, Chen L, Yi B, et al
    Increasing seasonal influenza vaccination among high risk groups in China: Do community healthcare workers have a role to play?
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30851.
    PubMed     Text format     Abstract available


  363. HATTA Y, Boltz D, Sarawar S, Kawaoka Y, et al
    M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30826.
    PubMed     Text format     Abstract available


  364. BEYER WEP, Palache AM, Boulfich M, Osterhaus ADME, et al
    Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials.
    Vaccine. 2017 Jun 24. pii: S0264-410X(17)30825.
    PubMed     Text format     Abstract available


  365. VENEREO-SANCHEZ A, Simoneau M, Lanthier S, Chahal P, et al
    Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30801.
    PubMed     Text format     Abstract available


  366. EL OMEIRI N, Azziz-Baumgartner E, Thompson MG, Clara W, et al
    Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30823.
    PubMed     Text format     Abstract available


  367. REPERANT LA, Osterhaus ADME
    AIDS, Avian flu, SARS, MERS, Ebola, Zika... what next?
    Vaccine. 2017 Jun 17. pii: S0264-410X(17)30583.
    PubMed     Text format     Abstract available


  368. CHRISTIAN LM, Beverly C, Mitchell AM, Karlsson E, et al
    Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30686.
    PubMed     Text format     Abstract available


  369. BLANCO JCG, Pletneva LM, Otoa RO, Patel MC, et al
    Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30786.
    PubMed     Text format     Abstract available


  370. DEPASSE JV, Nowalk MP, Smith KJ, Raviotta JM, et al
    Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.
    Vaccine. 2017 Jun 9. pii: S0264-410X(17)30763.
    PubMed     Text format     Abstract available


  371. WESTON D, Blackburn R, Potts HWW, Hayward AC, et al
    Predictors of self and parental vaccination decisions in England during the 2009 H1N1 pandemic: Analysis of the Flu Watch pandemic cohort data.
    Vaccine. 2017 Jun 7. pii: S0264-410X(17)30720.
    PubMed     Text format     Abstract available


  372. KURUPATI RK, Kossenkoff A, Kannan S, Haut LH, et al
    The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged.
    Vaccine. 2017 Jun 2. pii: S0264-410X(17)30733.
    PubMed     Text format     Abstract available


  373. AUGUST A, Glenn GM, Kpamegan E, Hickman SP, et al
    A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
    Vaccine. 2017 Jun 1. pii: S0264-410X(17)30681.
    PubMed     Text format     Abstract available


    May 2017
  374. HILGERS LAT, Platenburg PPLI, Bajramovic J, Veth J, et al
    Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses.
    Vaccine. 2017;35:3249-3255.
    PubMed     Text format     Abstract available


  375. SHIM SM, Song EJ, Song D, Lee TY, et al
    Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets.
    Vaccine. 2017 May 30. pii: S0264-410X(17)30689.
    PubMed     Text format     Abstract available


  376. PETIOT E, Proust A, Traversier A, Durous L, et al
    Influenza viruses production: Evaluation of a novel avian cell line DuckCelt(R)-T17.
    Vaccine. 2017 May 29. pii: S0264-410X(17)30502.
    PubMed     Text format     Abstract available


  377. BOES L, Boedeker B, Schmich P, Wetzstein M, et al
    Factors associated with parental acceptance of seasonal influenza vaccination for their children - A telephone survey in the adult population in Germany.
    Vaccine. 2017 May 27. pii: S0264-410X(17)30623.
    PubMed     Text format     Abstract available


  378. BERTRAN K, Balzli C, Lee DH, Suarez DL, et al
    Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
    Vaccine. 2017 May 26. pii: S0264-410X(17)30687.
    PubMed     Text format     Abstract available


  379. LONE NA, Spackman E, Kapczynski D
    Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
    Vaccine. 2017 May 13. pii: S0264-410X(17)30608.
    PubMed     Text format     Abstract available


  380. SEALY RE, Surman SL, Hurwitz JL
    CD4(+) T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.
    Vaccine. 2017;35:2617-2621.
    PubMed     Text format     Abstract available


  381. DIAZ A, Romero M, Vazquez T, Lechner S, et al
    Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.
    Vaccine. 2017;35:2694-2700.
    PubMed     Text format     Abstract available


  382. MILIAN E, Julien T, Biaggio R, Venereo-Sanchez A, et al
    Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30557.
    PubMed     Text format     Abstract available


  383. CHADA KE, Forshee R, Golding H, Anderson S, et al
    A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30507.
    PubMed     Text format     Abstract available


  384. ZERBO O, Modaressi S, Chan B, Goddard K, et al
    No association between influenza vaccination during pregnancy and adverse birth outcomes.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30575.
    PubMed     Text format     Abstract available


  385. HENDIN HE, Pillet S, Lara AN, Wu CY, et al
    Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
    Vaccine. 2017;35:2592-2599.
    PubMed     Text format     Abstract available


  386. SAHIN Z, Akkoc S, Neeleman R, Haines J, et al
    Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30558.
    PubMed     Text format     Abstract available


  387. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Text format     Abstract available


    April 2017
  388. ARRIOLA CS, Vasconez N, Thompson MG, Olsen SJ, et al
    Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua.
    Vaccine. 2017 Apr 29. pii: S0264-410X(17)30536.
    PubMed     Text format     Abstract available


  389. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258].
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30553.
    PubMed     Text format    


  390. ZHANG Y, Wu P, Feng L, Yang P, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30436.
    PubMed     Text format     Abstract available


  391. KAPCZYNSKI DR, Pantin-Jackwood MJ, Spackman E, Chrzastek K, et al
    Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30520.
    PubMed     Text format     Abstract available


  392. DOMBKOWSKI KJ, Cowan AE, Reeves SL, Foley MR, et al
    The impacts of email reminder/recall on adolescent influenza vaccination.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30511.
    PubMed     Text format     Abstract available


  393. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Near real-time surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30439.
    PubMed     Text format     Abstract available


  394. BAZAN M, Villacorta E, Barbagelatta G, Jimenez MM, et al
    Health workers' attitudes, perceptions and knowledge of influenza immunization in Lima, Peru: A mixed methods study.
    Vaccine. 2017 Apr 21. pii: S0264-410X(17)30485.
    PubMed     Text format     Abstract available


  395. WILKINSON K, Wei Y, Szwajcer A, Rabbani R, et al
    Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30444.
    PubMed     Text format     Abstract available


  396. NAKATSUKASA A, Kuruma K, Okamatsu M, Hiono T, et al
    Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30469.
    PubMed     Text format     Abstract available


  397. SUH J, Kim B, Yang Y, Suh DC, et al
    Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30480.
    PubMed     Text format     Abstract available


  398. DAUNER A, Agrawal P, Salvatico J, Tapia T, et al
    The in vitro MIMIC(R) platform reflects age-associated changes in immunological responses after influenza vaccination.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30451.
    PubMed     Text format     Abstract available


  399. SMITH TRF, Schultheis K, Morrow MP, Kraynyak KA, et al
    Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30468.
    PubMed     Text format     Abstract available


  400. VAN DOORN E, Darvishian M, Dijkstra F, Donker GA, et al
    Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30476.
    PubMed     Text format     Abstract available


  401. BERLANDA SCORZA F
    Advancing new vaccines against pandemic influenza in low-resource countries.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30446.
    PubMed     Text format     Abstract available


  402. MCLEAN HQ, Caspard H, Griffin MR, Poehling KA, et al
    Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30437.
    PubMed     Text format     Abstract available


  403. RAY GT, Lewis N, Goddard K, Ross P, et al
    Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30434.
    PubMed     Text format     Abstract available


  404. HOFSTETTER AM, Robinson JD, Lepere K, Cunningham M, et al
    Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30411.
    PubMed     Text format     Abstract available


  405. AIREY J, Albano FR, Sawlwin DC, Jones AG, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Apr 5. pii: S0264-410X(17)30334.
    PubMed     Text format     Abstract available


  406. LEUNG VK, Carolan LA, Worth LJ, Harper SA, et al
    Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.
    Vaccine. 2017 Apr 3. pii: S0264-410X(17)30390.
    PubMed     Text format     Abstract available


    March 2017
  407. IMBURGIA TM, Hendrix KS, Donahue KL, Sturm LA, et al
    Predictors of influenza vaccination in the U.S. among children 9-13years of age.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30387.
    PubMed     Text format     Abstract available


  408. OFSTEAD CL, Amelang MR, Wetzler HP, Tan L, et al
    Moving the needle on nursing staff influenza vaccination in long-term care: Results of an evidence-based intervention.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30357.
    PubMed     Text format     Abstract available


  409. HELLFRITZSCH M, Thomsen RW, Baggesen LM, Larsen FB, et al
    Lifestyle, socioeconomic characteristics, and medical history of elderly persons who receive seasonal influenza vaccination in a tax-supported healthcare system.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30356.
    PubMed     Text format     Abstract available


  410. FELL DB, Bhutta ZA, Hutcheon JA, Karron RA, et al
    Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30373.
    PubMed     Text format     Abstract available


  411. TSENG YF, Weng TC, Lai CC, Chen PL, et al
    A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography.
    Vaccine. 2017 Mar 22. pii: S0264-410X(17)30322.
    PubMed     Text format     Abstract available


  412. KOEPKE R, Schauer SL, Davis JP
    Measuring maternal Tdap and influenza vaccination rates: Comparison of two population-based methods.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30330.
    PubMed     Text format     Abstract available


  413. KANG GJ, Culp RK, Abbas KM
    Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30320.
    PubMed     Text format     Abstract available


  414. GUIOMAR R, Pereira da Silva S, Conde P, Cristovao P, et al
    Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
    Vaccine. 2017 Mar 15. pii: S0264-410X(17)30213.
    PubMed     Text format     Abstract available


  415. LANSBURY LE, Smith S, Beyer W, Karamehic E, et al
    Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30272.
    PubMed     Text format     Abstract available


  416. TREANOR JT, Albano FR, Sawlwin DC, Graves Jones A, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30291.
    PubMed     Text format     Abstract available


  417. TROGSTAD L, Bakken IJ, Gunnes N, Ghaderi S, et al
    Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30266.
    PubMed     Text format     Abstract available


  418. SEQUEIRA DP, Correia R, Carrondo MJ, Roldao A, et al
    Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30246.
    PubMed     Text format     Abstract available


  419. MOSNIER A, Daviaud I, Caini S, Berche H, et al
    Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30292.
    PubMed     Text format     Abstract available


  420. UI H, Yamayoshi S, Uraki R, Kiso M, et al
    Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30244.
    PubMed     Text format     Abstract available


  421. KURZ X, Bauchau V, Mahy P, Glismann S, et al
    The ADVANCE Code of Conduct for collaborative vaccine studies.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30242.
    PubMed     Text format     Abstract available


  422. TING EE, Sander B, Ungar WJ
    Systematic review of the cost-effectiveness of influenza immunization programs.
    Vaccine. 2017 Mar 8. pii: S0264-410X(17)30247.
    PubMed     Text format     Abstract available


  423. PROBST P, Grigg JB, Wang M, Munoz E, et al
    A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30118.
    PubMed     Text format     Abstract available


  424. GERSHWIN LJ, Behrens NE, McEligot HA, Carvallo-Chaigneau FR, et al
    A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30125.
    PubMed     Text format     Abstract available


  425. KUCK LR, Saye S, Loob S, Roth-Eichhorn S, et al
    VaxArray assessment of influenza split vaccine potency and stability.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30222.
    PubMed     Text format     Abstract available


    February 2017
  426. SMITH LE, Webster RK, Weinman J, Amlot R, et al
    Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: A cross-sectional survey in England.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30225.
    PubMed     Text format     Abstract available


  427. CHEUNG K, Ho SM, Lam W
    Factors affecting the willingness of nursing students to receive annual seasonal influenza vaccination: A large-scale cross-sectional study.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30164.
    PubMed     Text format     Abstract available


  428. MEIJER WJ, Wensing AM, Bos AA, Kuiphuis JC, et al
    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30145.
    PubMed     Text format     Abstract available


  429. MCHUGH L, Andrews RM, Lambert SB, Viney KA, et al
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155.
    PubMed     Text format     Abstract available


  430. LENNY BJ, Sonnberg S, Danner AF, Friedman K, et al
    Evaluation of multivalent H2 influenza pandemic vaccines in mice.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30061.
    PubMed     Text format     Abstract available


  431. MADAN A, Ferguson M, Sheldon E, Segall N, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30119.
    PubMed     Text format     Abstract available


  432. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al
    Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30088.
    PubMed     Text format     Abstract available


  433. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al
    Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30082.
    PubMed     Text format     Abstract available


  434. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30128.
    PubMed     Text format     Abstract available


  435. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE
    Impact of vaccination on influenza mortality in children <5years old in Mexico.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30087.
    PubMed     Text format     Abstract available


  436. BARMAN S, Krylov PS, Turner JC, Franks J, et al
    Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30127.
    PubMed     Text format     Abstract available


    January 2017
  437. ALAN H, Ian B, Nancy C, Ruben O D, et al
    Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30037.
    PubMed     Text format     Abstract available


  438. SMALL PA JR, Cronin BJ
    The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
    Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041.
    PubMed     Text format    


  439. DHAKAL S, Goodman J, Bondra K, Lakshmanappa YS, et al
    Polyanhydride nanovaccine against swine influenza virus in pigs.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30038.
    PubMed     Text format     Abstract available


  440. MORIYAMA M, Chino S, Ichinohe T
    Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30046.
    PubMed     Text format     Abstract available


  441. DAVID SC, Lau J, Singleton EV, Babb R, et al
    The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269.
    PubMed     Text format     Abstract available


  442. NAKAYAMA M, Itoh Y, Shichinohe S, Nakabayashi R, et al
    Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30013.
    PubMed     Text format     Abstract available


  443. YANG L, Nan H, Liang J, Chan YH, et al
    Influenza vaccination in older people with diabetes and their household contacts.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30007.
    PubMed     Text format     Abstract available


  444. QUINN SC, Jamison A, Freimuth VS, An J, et al
    Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adults.
    Vaccine. 2017 Jan 13. pii: S0264-410X(16)31271.
    PubMed     Text format     Abstract available


  445. TREANOR JJ, Chu L, Essink B, Muse D, et al
    Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Vaccine. 2017 Jan 11. pii: S0264-410X(16)31286.
    PubMed     Text format     Abstract available


  446. TAYLOR G
    Animal models of respiratory syncytial virus infection.
    Vaccine. 2017;35:469-480.
    PubMed     Text format     Abstract available


  447. HABIBI MS, Chiu C
    Controlled human infection with RSV: The opportunities of experimental challenge.
    Vaccine. 2017;35:489-495.
    PubMed     Text format     Abstract available


  448. MEJIAS A, Garcia-Maurino C, Rodriguez-Fernandez R, Peeples ME, et al
    Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection.
    Vaccine. 2017;35:496-502.
    PubMed     Text format     Abstract available


  449. CHIU C
    Novel immunological insights in accelerating RSV vaccine development.
    Vaccine. 2017;35:459-460.
    PubMed     Text format    


  450. ZHANG W, Hirve S, Kieny MP
    Seasonal vaccines - Critical path to pandemic influenza response.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31289.
    PubMed     Text format    


  451. COWLING BJ, Caini S, Chotpitayasunondh T, Djauzi S, et al
    Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31298.
    PubMed     Text format     Abstract available


  452. NEROME K, Matsuda S, Maegawa K, Sugita S, et al
    Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31291.
    PubMed     Text format     Abstract available


  453. LOWELL GH, Ziv S, Bruzil S, Babecoff R, et al
    Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31297.
    PubMed     Text format     Abstract available


  454. CESPEDES PF, Rey-Jurado E, Espinoza JA, Rivera CA, et al
    A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31273.
    PubMed     Text format     Abstract available


  455. LIN J, Xia J, Chen YT, Zhang KY, et al
    H9N2 avian influenza virus enhances the immune responses of BMDCs by down-regulating miR29c.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31287.
    PubMed     Text format     Abstract available


  456. YUDIN MH, Mistry N, De Souza LR, Besel K, et al
    Text messages for influenza vaccination among pregnant women: A randomized controlled trial.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31195.
    PubMed     Text format     Abstract available


    December 2016
  457. SAITO N, Komori K, Suzuki M, Morimoto K, et al
    Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31071.
    PubMed     Text format     Abstract available


  458. MILLMAN AJ, Reynolds S, Duffy J, Chen J, et al
    Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31258.
    PubMed     Text format     Abstract available


  459. LEE TY, Kim CU, Bae EH, Seo SH, et al
    Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31232.
    PubMed     Text format     Abstract available


  460. DOMNICH A, Arata L, Amicizia D, Puig-Barbera J, et al
    Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31218.
    PubMed     Text format     Abstract available


  461. MERTZ D, Geraci J, Winkup J, Gessner BD, et al
    Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31219.
    PubMed     Text format     Abstract available


  462. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Text format     Abstract available


  463. FUENTES S, Arenas D, Moore MM, Golding H, et al
    Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Vaccine. 2016 Dec 15. pii: S0264-410X(16)31105.
    PubMed     Text format     Abstract available


  464. YOUNG B, Zhao X, Cook AR, Parry CM, et al
    Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31044.
    PubMed     Text format     Abstract available


  465. PILKINTON MA, Nicholas KJ, Warren CM, Smith RM, et al
    Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31121.
    PubMed     Text format     Abstract available


  466. SONG JY, Cheong HJ, Hyun HJ, Seo YB, et al
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in 60-year-old adults.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31109.
    PubMed     Text format     Abstract available


  467. CHONG Y, Ikematsu H
    Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31156.
    PubMed     Text format     Abstract available


  468. HULO S, Nuvoli A, Sobaszek A, Salembier-Trichard A, et al
    Knowledge and attitudes towards influenza vaccination of health care workers in emergency services.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31158.
    PubMed     Text format     Abstract available


    November 2016
  469. ZHOU H, Huang Y, Yuan S, Li Y, et al
    Sequential immunization with consensus influenza hemagglutinins raises cross-reactive neutralizing antibodies against various heterologous HA strains.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31113.
    PubMed     Text format     Abstract available


  470. DE VRIES RD, Nieuwkoop NJ, Pronk M, de Bruin E, et al
    Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31154.
    PubMed     Text format     Abstract available


  471. PAN-NGUM W, Kinyanjui T, Kiti M, Taylor S, et al
    Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31023.
    PubMed     Text format     Abstract available


  472. VAN BAALEN CA, Jeeninga RE, Penders GH, van Gent B, et al
    ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31122.
    PubMed     Text format     Abstract available


  473. WANEESORN J, Wibowo N, Bingham J, Middelberg AP, et al
    Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31120.
    PubMed     Text format     Abstract available


  474. JIMENEZ-GARCIA R, Lopez-de-Andres A, Hernandez-Barrera V, Gomez-Campelo P, et al
    Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31100.
    PubMed     Text format     Abstract available


  475. SHEN Z, Bowen RA, Ge P, Yu J, et al
    Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Vaccine. 2016;34:5953-5958.
    PubMed     Text format     Abstract available


  476. ZHENG D, Chen S, Qu D, Chen J, et al
    Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31073.
    PubMed     Text format     Abstract available


  477. KANG J, Song YM
    Factors associated with vaccination status among Korean submariners who are eligible for free non-mandatory influenza vaccination.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31027.
    PubMed     Text format     Abstract available


  478. WALKER L, Newall A, Heywood AE
    Knowledge, attitudes and practices of Australian medical students towards influenza vaccination.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)31024.
    PubMed     Text format     Abstract available


  479. HUANG CH, Chao DY, Wu CC, Hsu SY, et al
    Influenza vaccination and the endurance against air pollution among elderly with acute coronary syndrome.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30989.
    PubMed     Text format     Abstract available


  480. PIELER MM, Frentzel S, Bruder D, Wolff MW, et al
    A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30976.
    PubMed     Text format     Abstract available


    October 2016
  481. LIU H, Frijlink HW, Huckriede A, van Doorn E, et al
    Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30975.
    PubMed     Text format     Abstract available


  482. MANENTI A, Tete SM, Mohn KG, Jul-Larsen A, et al
    Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30940.
    PubMed     Text format     Abstract available


  483. DVALISHVILI M, Mesxishvili D, Butsashvili M, Kamkamidze G, et al
    Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30954.
    PubMed     Text format     Abstract available


  484. ISENOR JE, Edwards NT, Alia TA, Slayter KL, et al
    Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis.
    Vaccine. 2016 Oct 17. pii: S0264-410X(16)30792.
    PubMed     Text format     Abstract available


  485. YANG J, Atkins KE, Feng L, Pang M, et al
    Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30911.
    PubMed     Text format     Abstract available


  486. KARKI S, Dyda A, Newall A, Heywood A, et al
    Comparison of influenza vaccination coverage between immigrant and Australian-born adults.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30910.
    PubMed     Text format     Abstract available


  487. MAERTENS K, Braeckman T, Top G, Van Damme P, et al
    Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30882.
    PubMed     Text format     Abstract available


  488. SITARAS I, Rousou X, Peeters B, de Jong MC, et al
    Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30894.
    PubMed     Text format     Abstract available


  489. ABADOM TR, Smith AD, Tempia S, Madhi SA, et al
    Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.
    Vaccine. 2016 Oct 6. pii: S0264-410X(16)30824.
    PubMed     Text format     Abstract available


    September 2016
  490. FITZGERALD TJ, Kang Y, Bridges CB, Talbert T, et al
    Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30833.
    PubMed     Text format     Abstract available


  491. GELLIN BG, Qadri F
    Preparing for the unpredictable: The continuing need for pandemic influenza preparedness.
    Vaccine. 2016 Sep 24. pii: S0264-410X(16)30836.
    PubMed     Text format    


  492. LIN X, Fiebelkorn AP, Pabst LJ
    Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010-2015.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30850.
    PubMed     Text format     Abstract available


  493. WILLIS E, Parkhouse K, Krammer F, Hensley SE, et al
    Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30830.
    PubMed     Text format     Abstract available


  494. LEVIN Y, Kochba E, Shukarev G, Rusch S, et al
    A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30804.
    PubMed     Text format     Abstract available


  495. WONG VW, Fong DY, Lok KY, Wong JY, et al
    Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30832.
    PubMed     Text format     Abstract available


  496. SLAUNWHITE JM, Smith SM, Halperin BA, Langley JM, et al
    The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30790.
    PubMed     Text format     Abstract available


  497. PUSHKO P, Sun X, Tretyakova I, Hidajat R, et al
    Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
    Vaccine. 2016 Sep 20. pii: S0264-410X(16)30825.
    PubMed     Text format     Abstract available


  498. ORTIZ JR, Perut M, Dumolard L, Wijesinghe PR, et al
    A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30643.
    PubMed     Text format     Abstract available


  499. NANNEI C, Goldin S, Torelli G, Fatima H, et al
    Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30712.
    PubMed     Text format     Abstract available


  500. SPARROW E, Friede M, Sheikh M, Torvaldsen S, et al
    Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30744.
    PubMed     Text format     Abstract available


  501. SCHMIDT R, Holznagel E, Neumann B, Alex N, et al
    Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase.
    Vaccine. 2016 Sep 8. pii: S0264-410X(16)30789.
    PubMed     Text format     Abstract available


  502. NANNEI C, Chadwick C, Fatima H, Goldin S, et al
    Considerations for sustainable influenza vaccine production in developing countries.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30743.
    PubMed     Text format     Abstract available


  503. CASPARD H, Coelingh KL, Mallory RM, Ambrose CS, et al
    Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
    Vaccine. 2016 Sep 6. pii: S0264-410X(16)30786.
    PubMed     Text format     Abstract available


    August 2016
  504. ROBERTS JN, Graham BS, Karron RA, Munoz FM, et al
    Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
    Vaccine. 2016 Aug 23. pii: S0264-410X(16)30655.
    PubMed     Text format     Abstract available


  505. OHANNESSIAN R, Yaghobian S, Verger P, Vanhems P, et al
    A systematic review of serious video games used for vaccination.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30646.
    PubMed     Text format     Abstract available


    May 2016
  506. GRAHAM BS
    Vaccines against respiratory syncytial virus: The time has finally come.
    Vaccine. 2016 May 13. pii: S0264-410X(16)30257.
    PubMed     Text format     Abstract available


  507. MOWBRAY F, Marcu A, Godinho CA, Michie S, et al
    Communicating to increase public uptake of pandemic flu vaccination in the UK: Which messages work?
    Vaccine. 2016 May 8. pii: S0264-410X(16)30278.
    PubMed     Text format     Abstract available


    February 2016
  508. TUCKERMAN J, Thomas N, Marshall HS
    Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00122.
    PubMed     Text format     Abstract available


    January 2016
  509. BATES JT, Pickens JA, Schuster JE, Johnson M, et al
    Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
    Vaccine. 2016 Jan 7. pii: S0264-410X(15)01842.
    PubMed     Text format     Abstract available


  510. ZHANG Y, Qiao L, Hu X, Zhao K, et al
    Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection.
    Vaccine. 2016;34:252-60.
    PubMed     Text format     Abstract available


  511. GARG R, Latimer L, Wang Y, Simko E, et al
    Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs.
    Vaccine. 2016;34:261-9.
    PubMed     Text format     Abstract available


  512. KRISTENSEN M, van Lier A, Eilers R, McDonald SA, et al
    Burden of four vaccine preventable diseases in older adults.
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01863.
    PubMed     Text format     Abstract available


    December 2015
  513. DETERMANN D, de Bekker-Grob EW, French J, Voeten HA, et al
    Future pandemics and vaccination: Public opinion and attitudes across three European countries.
    Vaccine. 2015 Dec 28. pii: S0264-410X(15)01832.
    PubMed     Text format     Abstract available


    October 2015
  514. MAUNDER HE, Taylor G, Leppard KN, Easton AJ, et al
    Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01561.
    PubMed     Text format     Abstract available


  515. ALQAHTANI AS, Alfelali M, Arbon P, Booy R, et al
    Burden of vaccine preventable diseases at large events.
    Vaccine. 2015 Oct 2. pii: S0264-410X(15)01352.
    PubMed     Text format     Abstract available


    June 2015
  516. MODJARRAD K, Giersing B, Kaslow DC, Smith PG, et al
    WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
    Vaccine. 2015 Jun 19. pii: S0264-410X(15)00767.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: